William D. Waddill, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 3,000 shares at $73.10 ($214K) on 2020-12-10, disclosed to the SEC on 2020-12-11.
Open-market sale of $214k ARWR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $68.50 | 1,200 | $82K | 38.5% |
| 2 | $73.10 | 1,800 | $132K | 61.5% |
| Total | $71.26 avg | 3,000 | $214K | 100% |
| Filing → |
| PTGX | SELL | 2026-06-01 | $897K | — | Filing → |
| PTGX | SELL | 2026-02-06 | $1.7M | — | Filing → |
| ARWR | SELL | 2025-12-23 | $1.1M | — | Filing → |